SCHEMBL16169701

SCHEMBL16169701

CC(=N)NCCCOc1cc(OCCCNC(=N)N)cc(-c2ccc3sc4ccc(-c5cc(OCCCN)cc(OCCCN)c5)cc4c3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CSF3R Q99062 1/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ F9 P00740 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16169694 0.96 F9 (0.34) CSF3RPIM1PIM2F9L3MBTL1
SCHEMBL16169703 0.94 PIM1 (0.33) CSF3RPIM1PIM2
SCHEMBL15805867 0.90 F9 (0.36) F9
SCHEMBL16169705 0.83 F9 (0.32) F9
SCHEMBL15805864 0.81 PIM1 (0.43) CSF3RPIM1PIM2F9
SCHEMBL16419736 0.80 L3MBTL1 (0.40) L3MBTL1
SCHEMBL15036995 0.79 PRSS1 (0.38) CSF3RL3MBTL1
SCHEMBL16169704 0.78 PIM1 (0.44) CSF3RPIM1PIM2
SCHEMBL16172090 0.77 F9 (0.33) F9
SCHEMBL16419740 0.77 L3MBTL1 (0.45) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140308317-A1 Polymeric Compounds And Methods Of Making And Using The Same CELLCEUTIX CORPORATION (US) 2014-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140308317-A1 Polymeric Compounds And Methods Of Making And Using The Same ALG1, CD44, MUC1 CSF3R 1989/4885PIM1 1725/4885PIM2 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback